Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sanofi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- GOLDMAN SACHS GROUP INC - $27.32M in ATTO purchases and sales in the last 12 months
- Colin Walsh - $27.32M in ATTO purchases and sales in the last 12 months
- Redmile Group, LLC - $10.20M in ATTO purchases and sales in the last 12 months
- Frazier Life Sciences XI, L.P. - $10.00M in ATTO purchases and sales in the last 12 months
- venBio Global Strategic Fund IV, L.P. - $6.50M in ATTO purchases and sales in the last 12 months
- Foresite Capital Management V, LLC - $2.52M in LTGO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sanofi?
Sanofi is a corporate insider, tracked as 10% Owner of Latigo Biotherapeutics, Inc. (LTGO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sanofi submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Sanofi been buying or selling stock?
Recorded transactions: 1 open-market purchase ($5.10M) and 0 open-market sales across all tracked filings.
